Please login to the form below

Not currently logged in

Bavarian Nordic

This page shows the latest Bavarian Nordic news and features for those working in and with pharma, biotech and healthcare.

Merck claims first-ever okay for Ebola vaccine, in Europe

Merck claims first-ever okay for Ebola vaccine, in Europe

Another vaccine – MVA-BN-Filo from Bavarian Nordic – is in late-stage testing in Uganda.

Latest news

More from news
Approximately 3 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2015 Deal Watch December 2015

    200. Bavarian Nordic (DK). Janssen. Collaboration, licence. Vaccine platform technology for development of treatment for cancers induced by HPV.

  • The world is our laboratory The world is our laboratory

    The vaccine regimen, which was discovered in a collaborative research programme with the National Institutes of Health, combines our preventative vaccine with a vaccine from Bavarian Nordic, a biotechnology company based ... Our commitment also included

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    1, 100. Bavarian Nordic / BMS. Option to license and commercialise.

  • Pharma deals in March 2015 Pharma deals in March 2015

    Fortunately, at end 2014 Bavarian Nordic was profitable and had over $175m in cash and an R&D cost of around $85m per year. ... One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich.

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    Identifying new agents in asthma and COPD. 196. Bavarian Nordic/J&J. Licence and supply.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...